Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
about
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress DisordersCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersThe effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorderRegulator of calcineurin 1 modulates expression of innate anxiety and anxiogenic responses to selective serotonin reuptake inhibitor treatment.Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetineManagement of anxiety disorders: the added challenge of comorbidity.The prediction of nonresponse to pharmacotherapy in panic disorder: a review.Serotonergic drugs in the treatment of depressive and anxiety disorders.Efficacy of chronic antidepressant treatments in a new model of extreme anxiety in rats.Treatment-resistant panic disorder.Serotonin function in panic disorder: important, but why?Fluvoxamine in the treatment of anxiety disorders.Panic disorder: is the PAG involved?A review of clinical efficacy of 5-HT 1A agonists in anxiety and depression.The value of selective serotonin re-uptake inhibitors (SSRIs) in the treatment of panic disorder with and without agoraphobia.Pharmacokinetic evaluation of fluvoxamine for the treatment of anxiety disorders.Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.The role of serotonin in panic: evidence from tryptophan depletion studies.Antidepressants and benzodiazepines for panic disorder in adults.Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole.5-HT2 receptor antagonism and slow-wave sleep in major depression.SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis.Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers.Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation.Double-blind pilot trial of desipramine versus fluoxetine in panic patients.Biphasic effects of selective serotonin reuptake inhibitors on anxiety: rapid reversal of escitalopram's anxiogenic effects in the novelty-induced hypophagia test in mice?Effects of tryptophan depletion on anxiety induced by simulated public speaking.Biological concepts of anxiety disorders.Ritanserin facilitates anxiety in a simulated public-speaking paradigm.
P2860
Q22305681-84244808-7144-4A8F-A354-9DB91A25444AQ27009995-95665546-3301-4EE2-8FF2-54D418E0CE42Q28296985-FAA39481-2962-4114-968B-2243B80999B9Q30439788-E4A8A964-6083-4E7C-B42E-AFA923F9C2FBQ33756416-14C07385-C96B-4679-B525-171BED60ABC0Q34218830-FA7C6A52-E9D8-407F-883F-4AD20CB1193EQ34415549-24EE612F-DA8D-4C12-91A7-C593515B41ECQ34982492-254D0811-5393-4068-B12D-2D618B3C20C3Q35131044-BAB6F251-DD5D-44A5-B7A2-E5069582A916Q35901886-349AF72A-09D8-4102-8A5E-708E0088A4D9Q36244896-552D6DC2-4575-4C2F-A7CE-9A5AFFE023A6Q36713425-BDCB93B7-D95C-4D32-92C9-C96B4A0AF9D6Q37124898-1FE764A9-4A9A-4808-8F8D-E2C90D71615EQ37980080-75AF57C7-D3F0-4D36-BBC0-58B0DD17E03AQ38220027-616717A5-4ADD-41B7-A4AA-2CDEFB9DA5DCQ38366480-9D0A4367-0A4B-472C-8004-29C807595B48Q38573611-097EB963-08F8-42BF-B50F-2B0A7EC305CFQ38777492-F0DDAD35-3E6E-486F-9775-1C87F6357051Q38952014-87EC797F-3077-4AFD-84D5-EC79F63E26C0Q41973984-3193471D-70EA-4B4A-9F77-3B8C9033CE29Q44085915-8A9A480D-7283-4B3A-9EB0-C572A54735C5Q44115958-28EB1194-418B-4E6E-8C19-9B1773ABFFABQ45043258-7E3EE039-6D36-4950-B394-9C2BB853571FQ46104700-A691EB2B-B173-4FC1-80B1-CFBFD4E9BC75Q46143700-D39BCCF7-923E-4EBD-98FA-21ABB3B743B3Q47787195-2A1304AB-7D80-408F-93D0-42FC26B24E02Q51081389-C6600FE5-4276-41D7-BC11-1942DF3A48A3Q51102530-CE25401D-33D4-4C52-9A09-5720B27842A7Q51107407-C2A1CB96-5C0B-4730-B27F-99B97A2D8C8A
P2860
Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Serotonin function in panic di ...... th fluvoxamine and ritanserin.
@en
type
label
Serotonin function in panic di ...... th fluvoxamine and ritanserin.
@en
prefLabel
Serotonin function in panic di ...... th fluvoxamine and ritanserin.
@en
P2860
P356
P1433
P1476
Serotonin function in panic di ...... th fluvoxamine and ritanserin.
@en
P2093
H G Westenberg
J A Den Boer
P2860
P2888
P356
10.1007/BF02245749
P577
1990-01-01T00:00:00Z
P6179
1019498587